These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 11531866

  • 1. Liver transplantation for early-detected, multifocal hepatocellular carcinoma.
    Salizzoni M, Zamboni F, Lupo F, Franchello A, David E, Rizzetto M.
    Br J Surg; 2001 Sep; 88(9):1194-5. PubMed ID: 11531866
    [No Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma: surgical treatment options.
    Gonzalez KB, Woodall M.
    Nurs Clin North Am; 2001 Sep; 36(3):593-602, xii. PubMed ID: 11532672
    [Abstract] [Full Text] [Related]

  • 3. Are the Hangzhou criteria adaptable to hepatocellular carcinoma patients for liver transplantation in Western countries?
    Audet M, Panaro F, Piardi T, Wolf P.
    Liver Transpl; 2009 Jul; 15(7):822-3; author reply 824-6. PubMed ID: 19562722
    [No Abstract] [Full Text] [Related]

  • 4. Role of locoregional therapy for hepatocellular carcinoma before liver transplantation: answer or myth?
    Huo TI, Lee SD, Wu JC.
    Liver Transpl; 2006 Oct; 12(10):1560; author reply 1561. PubMed ID: 17004251
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of recurrent hepatocellular carcinoma after liver transplantation.
    Davis E, Wiesner R, Valdecasas J, Kita Y, Rossi M, Schwartz M.
    Liver Transpl; 2011 Oct; 17 Suppl 2():S162-6. PubMed ID: 21688382
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Orthotopic liver transplantation in hepatocellular carcinoma: comparison of results in incidental and known hepatocellular carcinoma.
    Toufeeq Khan TF, Reddy KS, Johnston TD, Ranjan D.
    Int Surg; 2006 Oct; 91(4):185-7. PubMed ID: 16967677
    [Abstract] [Full Text] [Related]

  • 13. Management of hepatocellular carcinoma in the age of liver transplantation.
    Martin AP.
    Int J Surg; 2009 Aug; 7(4):324-9. PubMed ID: 19643691
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J.
    Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
    [Abstract] [Full Text] [Related]

  • 16. Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis.
    Del Gaudio M, Grazi GL, Principe A, Ravaioli M, Ercolani G, Cescon M, Varotti G, Gardini A, Cavallari A.
    Hepatogastroenterology; 2004 Jan; 51(56):510-4. PubMed ID: 15086193
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
    Vauthey JN, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, Lerut J, Chapman WC, Hemming AW, Neuhaus P.
    J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
    [Abstract] [Full Text] [Related]

  • 18. [Effective evaluation of liver transplantation for hepatocellular carcinoma].
    Song SB, Zhang TL, Xiu DR, Yuan J, Wang DC, Jiang B, Wang CM.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 17; 84(18):1533-5. PubMed ID: 15500714
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppression and hepatocellular carcinoma.
    Schlitt HJ, Mornex F, Shaked A, Trotter JF.
    Liver Transpl; 2011 Oct 17; 17 Suppl 2():S159-61. PubMed ID: 21506251
    [No Abstract] [Full Text] [Related]

  • 20. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time.
    Yoo HY, Patt CH, Geschwind JF, Thuluvath PJ.
    J Clin Oncol; 2003 Dec 01; 21(23):4329-35. PubMed ID: 14581446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.